A 59-year-old man with long-term smoking presents with progressive dyspnoea. Spirometry shows FEV₁/FVC ratio 0.60 and FEV₁ 65% predicted. He has sympt...

Question

A 59-year-old man with long-term smoking presents with progressive dyspnoea. Spirometry shows FEV₁/FVC ratio 0.60 and FEV₁ 65% predicted. He has symptoms on exertion but no recent exacerbations. According to CTS COPD guidelines, what is the most appropriate initial long-acting pharmacologic therapy?

Accepted Answer

Start long-acting muscarinic antagonist (LAMA) monotherapy

Answer

No inhaled therapy is indicated at this stage

Answer

Start inhaled corticosteroid monotherapy

Answer

Start LAMA plus inhaled corticosteroid combination therapy

Answer

Start chronic oral corticosteroids

ca-mccqe1 MCQ (SBA): Stable COPD initial pharmacotherapy